PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
495.53%
Net income growth under 50% of CRON.TO's 3699.18%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
23.54%
D&A growth well above CRON.TO's 9.86%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
200.89%
Lower deferred tax growth vs. CRON.TO's 1596.34%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-14.46%
Negative yoy SBC while CRON.TO is 113.22%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-67.75%
Both reduce yoy usage, with CRON.TO at -45.94%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-89.90%
Both yoy AR lines negative, with CRON.TO at -85.15%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-34.78%
Both reduce yoy inventory, with CRON.TO at -329.85%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-71.73%
Negative yoy AP while CRON.TO is 136.84%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
2.70%
Some yoy usage while CRON.TO is negative at -125.15%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-842.63%
Both negative yoy, with CRON.TO at -16930.83%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-128.34%
Both yoy CFO lines are negative, with CRON.TO at -174.10%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
6.98%
Lower CapEx growth vs. CRON.TO's 64.37%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
83.74%
Some acquisitions while CRON.TO is negative at -448.56%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-179.19%
Both yoy lines negative, with CRON.TO at -949.52%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-11.40%
We reduce yoy sales while CRON.TO is 50861.20%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-2356.01%
Both yoy lines negative, with CRON.TO at -290.04%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
3.89%
Lower net investing outflow yoy vs. CRON.TO's 87.17%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
99.52%
Debt repayment growth of 99.52% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.